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SPG7 and AFG3L are m-AAA proteases that form homo-oligomeric complexes and perform
essential functions in mitochondrial quality control (Quirós et al., 2015). Mutations of the SPG7
and AFG3L genes cause an autosomal recessive form of hereditary spastic paraplegia (Casari
et al., 1998) and spinocerebellar ataxia (Atorino et al., 2003; Di Bella et al., 2010), respectively,
as well as other neurological syndromes (Pierson et al., 2011). Mitochondrial dysfunction plays
a fundamental role in disease onset, as suggested by decreased activity of respiratory complex
I and increased sensitivity to reactive oxygen species (Atorino et al., 2003). König et al. now
show that m-AAA proteases assist in the correct formation of the mitochondrial Ca2+ uniporter
(MCU) complex by regulating the levels of its essential subunit EMRE (König et al., 2016). The
study provides a potential mechanistic link between m-AAA protease dysfunction, deregulation
of Ca2+ homeostasis and opening of the permeability transition pore (PTP), a high conductance
channel that requires matrix Ca2+ and is stimulated by oxidative stress (Bernardi et al., 2015).
The suggestion that SPG7 is part of the PTP (Shanmughapriya et al., 2015) is seriously questioned
by the findings of the article covered in this editorial, supporting the view outlined in a previous
commentary (Bernardi and Forte, 2015).
In energized mitochondria the Ca2+ electrochemical gradient drives Ca2+ uptake through the
MCU (Baughman et al., 2011; De Stefani et al., 2011). MCU function is affected by the regulatory
subunits MICU1 (Perocchi et al., 2010), MICU2 (Plovanich et al., 2013), the MCU inhibitory
paralog MCUb (Raffaello et al., 2013) and EMRE (Sancak et al., 2013), a sensor for matrix Ca2+
and a critical gatekeeper for the MCU (Vais et al., 2016). In the absence of EMRE (which faces the
matrix) MCU currents are no longer inhibited by matrix Ca2+ (which would normally limit its
accumulation) resulting in enhanced mitochondrial Ca2+ uptake and elevation of matrix [Ca2+]
(Vais et al., 2016). It was already known (and somewhat puzzling) that EMRE-dependent regulation
of MCU channel activity requires both MICU1 and MICU2, which are localized on the opposite
side of the inner membrane and face the intermembrane space (Vais et al., 2016). The results of
König et al. bear on this issue with the novel finding that EMRE is a substrate ofm-AAA proteases
in the intermembrane space before its import and incorporation into the MICU1-MICU2 complex
during the dynamic processes that ultimately generate the complete, regulated MCU complex.
In the absence of adequate m-AAA protease activity, the excess EMRE associates with the MCU
in a complex that lacks MICU1 and MICU2 (König et al., 2016). This unprocessed, unregulated
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MCU-EMRE complex would not be inhibited by matrix Ca2+
and thus mediate excessive mitochondrial Ca2+ uptake, leading
to opening of the PTP and to all its detrimental consequences
linked to deregulation of Ca2+ homeostasis and ATP depletion
(Bernardi et al., 2015). Consistent with this picture, mitochondria
from HeLa cells and from mice lacking SPG7 and/or AFG3L
displayed increased sensitivity to Ca2+-induced PTP opening
(König et al., 2016), as measured with the Ca2+ retention
capacity (CRC) assay, i.e., the amount of Ca2+ needed to trigger
pore opening. This is the opposite of what was reported by
Shanmughapriya et al. who carried out a phenotypic screen of the
CRC in permeabilized cells after inactivation of a variety of genes.
According to this report, SPG7 downregulation desensitized the
PTP by rendering it less sensitive to Ca2+ (Shanmughapriya
et al., 2015). In contrast, König et al. find that depletion of SPG7
facilitated PTP opening under all conditions tested (König et al.,
2016). Irrespective of the basis for this discrepancy, which might
depend on complementation by homo-oligomeric AFG3L2 and
will need further investigation, the predictions of the two sets of
opposing findings can be matched against the known hallmarks
of diseases linked to mutations ofm-AAA proteases.
Mitochondrial dysfunction is of pathogenic relevance to
neurodegenerative disorders due to mutations of m-AAA
proteases. This is clearly indicated by the presence of abnormal,
often swollen mitochondria (Casari et al., 1998; Atorino
et al., 2003; Ferreirinha et al., 2004; Di Bella et al., 2010;
Almajan et al., 2012), which is the expected outcome of
PTP opening (Bernardi et al., 2015). The second element is
derangement of Ca2+ homeostasis since both downregulation
of the glutamate receptor, which mediates Ca2+-dependent PTP
opening (Schinder et al., 1996), and decrease of cytosolic [Ca2+]
suppressed ataxia in an AFG3L2-deficent mouse (Maltecca et al.,
2015). Thus, the pathological alterations are best explained
by PTP sensitization (König et al., 2016) rather than by PTP
inhibition (Shanmughapriya et al., 2015). It should be noted that
decreased activity of respiratory complex I and increased reactive
oxygen species (Atorino et al., 2003) can cause sensitization
to PTP opening even if the increase of mitochondrial [Ca2+]
is not large (e.g., Figure 6C). m-AAA proteases possess only
2 hydrophobic regions (Casari et al., 1998; Banfi et al., 1999)
and are therefore unlikely to form high-conductance channels.
We think that this missing piece of evidence, which is essential
to substantiate the claim that SPG7 is a constituent of the
PTP (Shanmughapriya et al., 2015), should be provided before
this hypothesis can be considered further. For the time being
we believe that an indirect, PTP inducing effect of defective
m-AAA proteases is the most plausible explanation for the
pathogenesis of neurological diseases due to mutations in their
genes. Formation of deregulated MCU complexes provides a
provocative but testable mechanism for the increased probability
of PTP opening.
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